Financial Advocates Investment Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-481,769
Closed -$3.96M 747
2023
Q1
$3.96M Buy
481,769
+31,408
+7% +$347K 0.28% 87
2022
Q4
$5.02M Buy
450,361
+416,210
+1,219% +$4.84M 0.37% 67
2022
Q3
$405K Buy
34,151
+19,730
+137% +$299K 0.03% 466
2022
Q2
$220K Sell
14,421
-1,193
-8% -$21.5K 0.02% 602
2022
Q1
$330K Sell
15,614
-19,986
-56% -$431K 0.02% 549
2021
Q4
$841K Buy
35,600
+4,382
+14% +$93.9K 0.05% 360
2021
Q3
$627K Sell
31,218
-42,523
-58% -$871K 0.04% 426
2021
Q2
$1.48M Buy
73,741
+18,435
+33% +$394K 0.1% 244
2021
Q1
$1.18M Sell
55,306
-16,582
-23% -$357K 0.08% 278
2020
Q4
$1.57M Sell
71,888
-1,462
-2% -$28.5K 0.11% 220
2020
Q3
$1.29M Sell
73,350
-106,712
-59% -$1.99M 0.11% 202
2020
Q2
$3.38M Buy
+180,062
New +$3.19M 0.32% 78

Other funds holding MPT

Financial Advocates Investment Management's MPT Position: Q2 2023 in Review

Financial Advocates Investment Management sold out of Medical Properties Trust (MPT) in Q2 2023, closing a stake of 481,769 shares — an estimated $3.96M sold.

Financial Advocates Investment Management first reported a position in MPT in Q2 2020 and held it in 12 quarters. The position peaked at $5.02M in Q4 2022. 596 funds tracked by Wall St. Rank hold MPT as of Q2 2023.

  • Financial Advocates Investment Management reported no remaining Medical Properties Trust position as of Q2 2023 after selling out during the quarter.
  • Financial Advocates Investment Management sold 481,769 Medical Properties Trust shares in Q2 2023, an estimated $3.96M.
  • Financial Advocates Investment Management first reported a position in Medical Properties Trust in Q2 2020 and held it in 12 quarters.
  • Financial Advocates Investment Management's Medical Properties Trust position peaked at $5.02M in Q4 2022.
  • 596 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2023.

Based on Financial Advocates Investment Management's 13F filing for Q2 2023, filed 7 Aug 2023.